<DOC>
	<DOCNO>NCT01510392</DOCNO>
	<brief_summary>The primary goal trial show optical coherence tomography ( OCT ) technology use effectively screen disease eye include glaucoma , macular disease keratoconus . Glaucoma disease cause permanent vision loss usually accompany increase eye pressure . Macular disease affect sharp , central vision . Keratoconus disease affect cornea ( clear surface cover colored part eye ) .</brief_summary>
	<brief_title>CEI Van Outreach Screening Study</brief_title>
	<detailed_description>The identification many eye disease would significantly benefit early detection available typical eye exam . Optical coherence tomography ( OCT ) image technology perform non-contact cross-sectional imaging tissue structure real time . It similar ultrasound B-mode imaging , except OCT measure intensity reflect light rather sound wave .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Participant undergo screen examination Casey Eye Institute Outreach Van . Participants must age 18 89 year old . Inability give inform consent . Inability maintain stable fixation OCT imaging</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Optical coherence tomography</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Macula</keyword>
	<keyword>Keratoconus</keyword>
	<keyword>Screening</keyword>
</DOC>